C
C01CA04 Dopamine
[C01CA] Adrenergic and dopaminergic agents
[C01C] CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
[C01] CARDIAC THERAPY
[C] Cardiovascular system
Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
MITOCHONDRIA TRANSPORT | 30 nM | 2h | rat | Hippocampal Neurons | time-lapse imaging experiments | decrease | 216 | |
Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 500mg/kg (500mg/kg) | National Technical Information Service. Vol. AD277-689, | |
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane | .beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride | 1, 4-(2-aminoethyl)- |
1,2-Benzenediol, 4-(2-aminoethyl)- | 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) | 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium |
13510-EP2269989A1 | 13510-EP2270011A1 | 13510-EP2272537A2 |
13510-EP2272825A2 | 13510-EP2272847A1 | 13510-EP2275420A1 |
13510-EP2277882A1 | 13510-EP2280010A2 | 13510-EP2281559A1 |
13510-EP2281815A1 | 13510-EP2281819A1 | 13510-EP2284169A1 |
13510-EP2284170A1 | 13510-EP2284171A1 | 13510-EP2286811A1 |
13510-EP2287161A1 | 13510-EP2287162A1 | 13510-EP2287165A2 |
13510-EP2287166A2 | 13510-EP2292620A2 | 13510-EP2295437A1 |
13510-EP2295439A1 | 13510-EP2298312A1 | 13510-EP2298313A1 |
13510-EP2298731A1 | 13510-EP2298734A2 | 13510-EP2298758A1 |
13510-EP2298759A1 | 13510-EP2298775A1 | 13510-EP2298776A1 |
13510-EP2301540A1 | 13510-EP2301933A1 | 13510-EP2305260A1 |
13510-EP2305633A1 | 13510-EP2305640A2 | 13510-EP2305644A1 |
13510-EP2305648A1 | 13510-EP2305650A1 | 13510-EP2305652A2 |
13510-EP2305656A1 | 13510-EP2305659A1 | 13510-EP2305664A1 |
13510-EP2305675A1 | 13510-EP2305689A1 | 13510-EP2308828A2 |
13510-EP2308867A2 | 13510-EP2308870A2 | 13510-EP2308875A1 |
13510-EP2311494A1 | 13510-EP2311801A1 | 13510-EP2311802A1 |
13510-EP2311803A1 | 13510-EP2311818A1 | 13510-EP2311827A1 |
13510-EP2311828A1 | 13510-EP2311835A1 | 13510-EP2314571A2 |
13510-EP2316470A2 | 13510-EP2316836A1 | 13510-EP2371814A1 |
153C5321-5FEE-4B0B-8925-F388F0EEEBD1 | 2-(3, 4-Dihydroxyphenyl)ethylamine | 2-(3,4-Dihydroxyphenyl)-1-ethanamine |
2-(3,4-dihydroxyphenyl) ethylamine | 2-(3,4-dihydroxyphenyl)ethylamine | 2-(4-Hydroxy-5-oxylatophenyl)-1-ethanaminium |
3,4-DihydroxyphenylA currencythylamin | 3,4-Dihydroxyphenylethylamine | 3,4-dihydroxyphenethylamine |
3- HYDROXYTYRAMINE | 3-Hydroxtyramine | 3-Hydroxytyramine |
3-Hydroxytyramine HCl salt | 4-(2-Amino-ethyl)-benzene-1,2-diol | 4-(2-Aminoethyl)-1,2-benzenediol |
4-(2-Aminoethyl)-1,2-benzenediol # | 4-(2-Aminoethyl)-1,2-benzenediol hydrochloride | 4-(2-Aminoethyl)-1,2-bezenediol |
4-(2-Aminoethyl)benzene-1,2-diol | 4-(2-Aminoethyl)catechol | 4-(2-Aminoethyl)pyrocatechol |
4-(2-aminoethyl)-pyrocatechol | 4-(2-aminoethyl)pyrocatechol;hydrochloride | 4-(2-azanylethyl)benzene-1,2-diol;hydrochloride |
51-61-6 | 62-31-7 (HYDROCHLORIDE) | AB00053463-12 |
AB00053463_13 | AB00053463_14 | AK100905 |
AKOS003790978 | ANW-54385 | ASL 279 |
BBL013043 | BCP34189 | BDBM55121 |
BIDD:ER0506 | BP-23276 | BPBio1_001123 |
BSPBio_001932 | Biomol-NT_000001 | C03758 |
CAS-51-61-6 | CCG-204675 | CHEBI:18243 |
CHEMBL59 | CTK4E3164 | D07870 |
DB00988 | DSSTox_CID_2420 | DSSTox_GSID_22420 |
DSSTox_RID_76584 | DTXSID6022420 | DivK1c_000780 |
Dopamin | Dopamina | Dopamina [INN-Spanish] |
Dopamine (INN) | Dopamine (USAN)(*hydrochloride*) | Dopamine [INN:BAN] |
Dopamine hydrochloride;dopamine hydrochloride;4-(2-aminoethyl)pyrocatechol hydrobromide | Dopaminum | Dopaminum [INN-Latin] |
Dophamine | EINECS 200-110-0 | FS-5341 |
FT-0698513 | GTPL940 | HMS3743I03 |
HSDB 3068 | Hydroxytyramin | IDI1_000780 |
IP 498 | Intropin (Salt/Mix) | Intropin [*hydrochloride*] |
KBio1_000780 | KBio2_001492 | KBio2_002388 |
KBio2_002484 | KBio2_004060 | KBio2_004956 |
KBio2_005052 | KBio2_006628 | KBio2_007524 |
KBio2_007620 | KBio3_001152 | KBio3_002867 |
KBio3_002962 | KBioGR_001129 | KBioGR_002388 |
KBioGR_002484 | KBioSS_001492 | KBioSS_002393 |
KBioSS_002491 | KW-3-060 | L-DOPAMINE |
L000232 | LDP | LS-159 |
Lopac-H-8502 | Lopac0_000586 | MCULE-7558764100 |
Medopa (TN) | NCGC00015519-01 | NCGC00015519-02 |
NCGC00015519-03 | NCGC00015519-04 | NCGC00015519-05 |
NCGC00015519-07 | NCGC00015519-08 | NCGC00015519-09 |
NCGC00015519-10 | NCGC00015519-11 | NCGC00096050-01 |
NCGC00096050-02 | NCGC00096050-03 | NCGC00096050-04 |
NCGC00096050-05 | NINDS_000780 | NS00000608 |
NSC 173182 | NSC-173182 | NSC169105 |
NSC173182 | Oprea1_088821 | Oseltamivir-d3;Hydroxytyramin;4-(2-Aminoethyl)benzene-1,2-diol |
Oxytyramine | Pyrocatechol, 4-(2-aminoethyl)- | Pyrocatechol, 4-(2-aminoethyl)- (8CI) |
Q170304 | SBB004044 | SBI-0050568.P004 |
SCHEMBL8505 | SDCCGSBI-0050568.P005 | SPBio_001205 |
SPECTRUM1505155 | SR-01000075366 | SR-01000075366-7 |
ST048774 | STK301601 | Sinemet |
Spectrum2_001023 | Spectrum3_000406 | Spectrum4_000525 |
Spectrum5_000945 | Spectrum_001012 | T7923 |
Tox21_110167 | Tox21_110167_1 | UNII-VTD58H1Z2X |
UPCMLD0ENAT5885989:001 | VTD58H1Z2X | ZINC33882 |
a-(3,4-Dihydroxyphenyl)-b-aminoethane | alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane | bmse000909 |
bmse000933 | cMAP_000036 | cMAP_000065 |
cid_65340 | dopamine | hydroxytyramine |
intropin | m-Hydroxytyramine- |